Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma.

Fiche du document

Date

1 août 2021

Type de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2020.247023

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32675224

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1592-8721

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_B72746EA3CA73

Licences

info:eu-repo/semantics/openAccess , CC BY-NC 4.0 , https://creativecommons.org/licenses/by-nc/4.0/




Citer ce document

C.W. Thorball et al., « Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma. », Serveur académique Lausannois, ID : 10.3324/haematol.2020.247023


Métriques


Partage / Export

Résumé 0

Human immunodeficiency virus (HIV) infection is associated with an increased risk of non-Hodgkin lymphoma (NHL). Even in the era of suppressive antiretroviral treatment, HIV-infected individuals remain at higher risk of developing NHL compared to the general population. To identify potential genetic risk loci, we performed case-control genome-wide association studies and a meta-analysis across three cohorts of HIV+ patients of European ancestry, including a total of 278 cases and 1924 matched controls. We observed a significant association with NHL susceptibility in the C-X-C motif chemokine ligand 12 (CXCL12) region on chromosome 10. A fine mapping analysis identified rs7919208 as the most likely causal variant (P = 4.77e-11), with the G>A polymorphism creating a new transcription factor binding site for BATF and JUND. These results suggest a modulatory role of CXCL12 regulation in the increased susceptibility to NHL observed in the HIV-infected population.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en